the republic logo

WADA signs deal with US drug maker to share information on substances that could be misused


MONTREAL — The World Anti-Doping Agency has signed a deal with a leading U.S.-based drug maker to share information about new performance-enhancing substances that could be misused by athletes.

WADA says Wednesday that the "long-term global agreement" with Pfizer, whose headquarters are in New York, allows the company to provide details about products that have a "probable or high risk of abuse in sport." In return, WADA will exchange information with Pfizer on substances that are being abused by athletes.

The deal is WADA's latest collaboration with pharmaceutical companies to help catch drug cheats, following an agreement with British company GlaxoSmithKline ahead of the London Olympics in 2012.

WADA director general David Howman says the agreement comes at a "crucial time" because the 2015 World Anti-Doping Code will soon be introduced.

Think your friends should see this? Share it with them!

Story copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Feedback, Corrections and Other Requests: AP welcomes feedback and comments from readers. Send an email to and it will be forwarded to the appropriate editor or reporter.

We also have more stories about:
(click the phrases to see a list)


Follow The Republic:

All content copyright ©2014 The Republic, a division of Home News Enterprises unless otherwise noted.
All rights reserved. Privacy policy.